Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Simufilam - Filana Therapeutics

Next Previous
Drug Profile

Simufilam - Filana Therapeutics

Alternative Names: C0105; C0105M; Filora; PTI-125; PTI-910; Simufilam hydrochloride; Sumifilam - Filana Therapeutics

Latest Information Update: 25 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pain Therapeutics
  • Developer Filana Therapeutics
  • Class Antidementias; Antiepileptic drugs; Ketones; Small molecules
  • Mechanism of Action FLNA protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Alzheimer's disease
  • Preclinical Epilepsy

Most Recent Events

  • 12 Mar 2026 Filana Therapeutics plans to submit responses including additional pre-clinical data and protocol design modifications for Epilepsy to the US FDA
  • 10 Mar 2026 Cassava Sciences is now called Filana Therapeutics
  • 31 Dec 2025 Filana Therapeutics receives Clinical Hold Letter for Epilepsy from the US FDA in December 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top